October 13, 2020 Comments Off on New patent for Catalyst Pharms drug FIRDAPSE Posted in: Patent Added Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on…
October 13, 2020 Comments Off on New patent for Astrazeneca Ab drug BYDUREON BCISE Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appear…